Edition:
United Kingdom

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

327.00SEK
19 Oct 2018
Change (% chg)

-2.40kr (-0.73%)
Prev Close
329.40kr
Open
332.00kr
Day's High
334.80kr
Day's Low
318.00kr
Volume
190,762
Avg. Vol
181,688
52-wk High
349.40kr
52-wk Low
184.50kr

Chart for

About

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which... (more)

Overall

Beta: 1.83
Market Cap(Mil.): kr7,554.32
Shares Outstanding(Mil.): 35.05
Dividend: --
Yield (%): --

Financials

  HMED.ST Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -4.39 -- --
ROI: -83.23 0.21 14.27
ROE: -83.96 1.17 15.99

BRIEF-Hansa Medical Q1 Operating Loss Widens To SEK 46.6 Million

* Q1 OPERATING LOSS SEK 46.6 MILLION VERSUS LOSS SEK 44.8 MILLION YEAR AGO

25 Apr 2018

Earnings vs. Estimates